SIOP Ependymoma I: Final results, long-term follow-up, and molecular analysis of the trial cohort-A BIOMECA Consortium Study.
Timothy A RitzmannRebecca J ChapmanJohn-Paul KildayNicola ThorpPiergiorgio ModenaRobert A DineenDonald MacarthurConor L MallucciTimothy JaspanKristian W PajtlerMarzia GiagnacovoThomas S JacquesSimon M L PaineDavid W EllisonEric BouffetRichard G GrundyPublished in: Neuro-oncology (2022)
Participants with totally resected ependymoma had the best outcomes. RR of STR to VEC exceeded the pre-specified efficacy criterion. However, cases of inaccurate stratification highlighted the need for rapid central review. 1q gain, H3K27me3 loss, and hTERT expression were all associated with poorer survival outcomes.